Atara Biotherapeutics, Inc. Quarterly Income Tax Expense (Benefit) in USD from Q4 2012 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Atara Biotherapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q4 2012 to Q2 2024.
  • Atara Biotherapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $0.000, a 100% decline year-over-year.
  • Atara Biotherapeutics, Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $16K, a 54.3% decline year-over-year.
  • Atara Biotherapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was $15K, a 25% increase from 2022.
  • Atara Biotherapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was $12K, a 73.9% decline from 2021.
  • Atara Biotherapeutics, Inc. annual Income Tax Expense (Benefit) for 2021 was $46K, a 207% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $16K $0 -$1K -100% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $17K $24K +$2K +9.09% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $15K $11K +$9K +450% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 $6K -$19K -$29K -290% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $35K $1K +$1K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 $34K $22K +$22K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $12K $2K -$28K -93.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 $40K $10K +$10K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 $30K $0 -$16K -100% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $46K $0 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $46K $30K Oct 1, 2021 Dec 31, 2021 10-K 2023-02-08
Q3 2021 $0 -$6K -100% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $16K +$15K +1500% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $0 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q3 2020 $6K +$6K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $1K +$1K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q3 2019 $0 $0 Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $0 -$3K -100% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q4 2018 -$44K -$47K -$31K -194% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 -$13K $0 $0 Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$13K $3K +$3K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 -$16K $0 -$2K -100% Jan 1, 2018 Mar 31, 2018 10-Q 2018-05-08
Q4 2017 -$14K -$16K -$16K Oct 1, 2017 Dec 31, 2017 10-K 2020-02-27
Q3 2017 $2K $0 -$7K -100% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 $9K $0 $0 Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-01
Q1 2017 $9K $2K -$1K -33.3% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 $10K $0 Oct 1, 2016 Dec 31, 2016 10-K 2019-02-26
Q3 2016 $7K +$18K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $0 Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 $3K +$1K +50% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q3 2015 -$11K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-04
Q1 2015 $2K +$24K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q1 2014 -$22K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q3 2013 -$13K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q4 2012 $17K Aug 22, 2012 Dec 31, 2012 10-K 2015-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.